(Report ID: 96045) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 14,045 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 96045 | Mar, 28, 2006 | 40 | Female |
List of drugs the patient takes:
| Name |
Abasia |
Abnormal Dreams |
Activities Of Daily Living Impaired |
Delusional Perception |
Dizziness |
Dysuria |
Feeling Hot |
Generalised Erythema |
Hepatic Enzyme Increased |
Hypersensitivity |
Pallor |
Paraesthesia Oral |
Sleep Disorder |
Tongue Disorder |
Tremor |
Results from eHealthMe: 14,045 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Abasia | 49 (0.35%) |
Abnormal Dreams | 170 (1.21%) |
Activities Of Daily Living Impaired | 114 (0.81%) |
Delusional Perception | 5 (0.04%) |
Dizziness | 995 (7.08%) |
Dysuria | 69 (0.49%) |
Feeling Hot | 85 (0.61%) |
Generalised Erythema | 3 (0.02%) |
Hepatic Enzyme Increased | 378 (2.69%) |
Hypersensitivity | 107 (0.76%) |
Pallor | 19 (0.14%) |
Paraesthesia Oral | 21 (0.15%) |
Sleep Disorder | 111 (0.79%) |
Tongue Disorder | 23 (0.16%) |
Tremor | 502 (3.57%) |
Death: 56 (3.17% of total reports)
Cancer: 18 (1.02% of total reports)
| Name | Count (% of total reports) |
1 | Nausea | 156 (8.82%) |
2 | Depression | 135 (7.64%) |
3 | Dizziness | 123 (6.96%) |
4 | Fatigue | 105 (5.94%) |
5 | Headache | 101 (5.71%) |
6 | Pain | 98 (5.54%) |
7 | Suicidal Ideation | 96 (5.43%) |
8 | Insomnia | 94 (5.32%) |
9 | Anxiety | 91 (5.15%) |
10 | Drug Withdrawal Syndrome | 85 (4.81%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Lyrica | 162 |
2 | Aspirin | 123 |
3 | Seroquel | 115 |
4 | Ambien | 110 |
5 | Nexium | 104 |
6 | Neurontin | 103 |
7 | Xanax | 103 |
8 | Trazodone Hcl | 97 |
9 | Klonopin | 92 |
10 | Chantix | 91 |
Death: 198 (1.41% of total reports)
Cancer: 75 (0.53% of total reports)
| Name | Count (% of total reports) |
1 | Nausea | 1,449 (10.32%) |
2 | Dizziness | 995 (7.08%) |
3 | Feeling Abnormal | 880 (6.27%) |
4 | Fatigue | 812 (5.78%) |
5 | Insomnia | 796 (5.67%) |
6 | Headache | 783 (5.57%) |
7 | Depression | 723 (5.15%) |
8 | Drug Ineffective | 672 (4.78%) |
9 | Somnolence | 618 (4.40%) |
10 | Anxiety | 573 (4.08%) |
| Name | Count |
1 | Seroquel | 652 |
2 | Neurontin | 649 |
3 | Aspirin | 631 |
4 | Ambien | 625 |
5 | Klonopin | 611 |
6 | Synthroid | 605 |
7 | Lipitor | 553 |
8 | Nexium | 550 |
9 | Lyrica | 514 |
10 | Xanax | 460 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
